MASH
Clinical trials for MASH explained in plain language.
Never miss a new study
Get alerted when new MASH trials appear
Sign up with your email to follow new studies for MASH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a once-daily pill help children with fatty liver disease?
Disease control Not yet recruitingThis trial tests an experimental oral drug called resmetirom in children aged 6 to 17 with metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis. The study aims to evaluate the drug's safety, how the body processes it, and its effects on the liver. Participan…
Matched conditions: MASH
Phase: PHASE2 • Sponsor: Madrigal Pharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New gut implant aims to tackle diabetes and obesity without surgery
Disease control Not yet recruitingThis study tests a temporary device placed in the upper small intestine to help control type 2 diabetes and obesity. The implant stays for 6 months and is then removed. Researchers will check if it lowers blood sugar (HbA1c), helps with weight loss, and improves liver health in p…
Matched conditions: MASH
Phase: NA • Sponsor: Trans-Duodenal Concepts GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC